{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:46:10Z","timestamp":1790934370957,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1093\/jac\/dkx177","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T15:08:25Z","timestamp":1494688105000},"page":"2548-2552","source":"Crossref","is-referenced-by-count":101,"title":["In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates"],"prefix":"10.1093","volume":"72","author":[{"given":"J. B.","family":"Buil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J. M. M.","family":"Rijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Birch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. J. G.","family":"Melchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,10]]},"reference":[{"key":"key\n\t\t\t\t20171012115506_dkx177-B1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B3","first-page":"1149","article-title":"Population-based analysis of invasive fungal infections, France, 2001-2010","volume":"20","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B4","first-page":"635","article-title":"Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis","volume":"24","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B5","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/jac\/dkw259","article-title":"Azole resistance surveillance in Aspergillus fumigatus: beneficial or biased?","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B6","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/jac\/dkv177","article-title":"High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B7","doi-asserted-by":"crossref","first-page":"pii\u202f=\u202f30300","DOI":"10.2807\/1560-7917.ES.2016.21.30.30300","article-title":"Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013","volume":"21","year":"2016","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/mmy\/myv118","article-title":"Aspergillus tubingensis: a major filamentous fungus found in the airways of patients with lung disease","volume":"54","year":"2016","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/13693780902803040","article-title":"In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus","volume":"48","year":"2010","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B11","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1073\/pnas.1608304113","article-title":"F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase","volume":"113","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B12","article-title":"Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B13","first-page":"10","article-title":"Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature","volume":"56","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles","volume":"57","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B15","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.3109\/13693786.2010.505206","article-title":"Invasive aspergillosis in developing countries","volume":"49","year":"2011","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.diagmicrobio.2011.08.006","article-title":"In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing","volume":"71","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B17","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/AAC.00637-15","article-title":"A novel Y319H substitution in CYP51C associated with azole resistance in Aspergillus flavus","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijid.2003.06.001","article-title":"Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus","volume":"8","year":"2004","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B19","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1128\/AAC.00686-11","article-title":"Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012115506_dkx177-B20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/TP.0b013e31825992f0","article-title":"Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis","volume":"94","year":"2012","journal-title":"Transplantation"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/9\/2548\/19540395\/dkx177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T11:55:16Z","timestamp":1507809316000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/72\/9\/2548\/3866428\/In-vitro-activity-of-the-novel-antifungal-compound"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,10]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,6,10]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx177","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9]]},"published":{"date-parts":[[2017,6,10]]}}}